Of particular importance in T2D is the ability of n-3 PUFAs to modulate the incretin function, as demonstrated by their capacity to enhance glucagon-like peptide-1 (GLP-1) secretion and sensitivity, thereby improving both insulin secretion and glycemic control. The gene discussed is INS; the disease is type 2 diabetes mellitus.